Liver cancer mortality among male prison inmates in Texas, 1992-2003

Preventive Medicine

Volumn 48, Issue 6, 2009, Pages 588-592

  Harzke, Amy J ^a   Baillargeon, Jacques G ^a   Goodman, Karen J ^b   Pruitt, Sandi L ^c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Hepatitis; Incarceration; Liver diseases; Malignancies; Prison; Time trend

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; LIVER CANCER; MALE; PRIORITY JOURNAL; PRISONER; TREND STUDY; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CONFIDENCE INTERVALS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; POISSON DISTRIBUTION; PREVALENCE; PRISONERS; PRISONS; RISK ASSESSMENT; TEXAS;

EID: 67349245167     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2009.03.011     Document Type: Article

References (36)

1. Alter M.J., Kruszon-Moran D., Nainan O.V., McQuillan G.M., Gao F., Moyer L.A., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341 (1999) 556-562
2. American Cancer Society, 2009. Liver cancer overview: how is liver cancer treated. Available at: http://www.cancer.org/docroot/cri/content/cri_2_2_4x_how_is_liver_cancer_treated_25.asp.
3. Armstrong G.L., Wasley A., Simard E.P., McQuillan G.M., Kuhnert W.L., and Alter M.J. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 144 (2006) 705-714
4. Baillargeon J., Wu H., Kelley M.F., Grady J., Linthicum L., and Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public. Health 117 (2003) 43-48
5. Baillargeon J., Snyder N., Paar D., Baillargeon G., Spaulding A., Pollock B.H., et al. Hepatocellular carcinoma prevalence and mortality in a male state prison population. Public. Health Rep. 124 (2009) 120-126
6. Beck A.J., and Maruschak L.M. Hepatitis Testing and Treatment in State Prisons. Bureau of Justice Statistics Special Report (NCJ 199173C) (2004), US Department of Justice, Washington, DC. http://www.ojp.usdoj.gov/bjs/pub/pdf/httsp.pdf Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/httsp.pdf
7. Beck A.J., and Mumola C.J. Prisoners in 1998. Bureau of Justice Statistics Special Report (NCJ 175687) (1999), US Department of Justice, Washington, DC. http://www.ojp.usdoj.gov/bjs/pub/pdf/p98.pdf Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/p98.pdf
8. Caetano R., and Tam T.W. Prevalence and correlates of DSM-IV and ICD-10 alcohol dependence: 1990 U.S. National Alcohol Survey. Alcohol. Alcohol. 30 (1995) 177-186
9. Centers for Disease Control and Prevention (CDC). Hepatitis B vaccination of inmates in correctional facilities-Texas, 2000-2002. MMWR Morb. Mortal. Wkly. Rep. 53 (2004) 681-683
10. El-Serag H.B., and Mason A.C. Risk factors for the rising rates of primary liver cancer in the United States. Arch. Intern. Med. 160 (2000) 3227-3230
11. El-Serag H.B., Davila J.A., Peterson N.J., and McGlynn K.A. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann. Intern. Med. 139 (2003) 817-823
12. Fazel S., Bains P., and Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 101 (2006) 181-191
13. Grant B.F., Dawson D.A., Stinson F.S., Chou S.P., Dufour M.C., and Pickering R.P. The 12-month prevalence of and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2000-2001. Drug Alcohol. Depend. 74 (2004) 223-234
14. Macalino G.E., Vlahov D., Sanford-Colby S., Patel S., Sabin K., Salas C., et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am. J. Public. Health. 94 (2004) 1218-1223
15. Mathew P., Elting L., Cooksley C., Owen S., and Lin J. Cancer in an incarcerated population. Cancer 104 (2005) 2197-2204
16. McClellan D.S., Farabee D., and Crouch B.M. Early victimization, drug use, and criminality: a comparison of male and female prisoners. Crim. Justice Behav. 24 (1997) 455-476
17. McGlynn K.A., Tarone R.E., and El-Serag H.B. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol. Biomarkers. Prev. 15 (2006) 1198-1203
18. Mitka M. Aging prisoners stressing health care system. JAMA 292 (2004) 423-424
19. Mumola C.J. Substance Abuse and Treatment, State and Federal Prisoners, 1997. Bureau of Justice Statistics Special Report (NCJ 172871) (1999), US Department of Justice, Washington, DC. http://www.ojp.usdoj.gov/bjs/pub/pdf/satsfp97.pdf Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/satsfp97.pdf
20. National Cancer Institute/Statistical Research and Applications, 2008. Joinpoint regression program: average annual percent change. Available at: http://srab.cancer.gov/joinpoint/aapc.html.
21. National Center for Health Statistics/Centers for Disease Control and Prevention. Instructions for Classifying the Underlying Cause-of-Death (2008), U.S. Department of Health and Human Services, Hyattsville, MD. http://www.cdc.gov/nchs/data/dvs/2a2008Final.pdf Available at: http://www.cdc.gov/nchs/data/dvs/2a2008Final.pdf
22. One in 100: Behind Bars in America, 2008. Washington, DC: Pew Center on the States. Available at: http://www.pewcenteronthestates.org/report_detail.aspx?id=35904.
23. Pisu M., Meltzer M.I., and Lyerla R. Cost-effectiveness of hepatitis B vaccination of prison inmates. Vaccine 21 (2002) 312-321
24. Reitsma J.B., Bonsel G.J., Gunning-Schepers L.J., and Tijssen J.G. Lack of standards in direct standardization. Am. J. Public. Health 90 (2000) 139-140
25. Rosen D.L., Schoenbach V.J., and Wohl D.A. All-cause and cause-specific mortality among men released from state prison, 1980-2005. Am. J. Public Health 98 (2008) 2278-2284
26. Ruiz J.D., Moliter F., and Plagenhoef J.A. Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS 16 (2002) 2236-2238
27. Sabol W.J., Minton T.D., and Harrison P.M. Prison and Jail Inmates at Midyear 2006. Bureau of Justice Statistics Bulletin (NCJ 217675) (2007), US Department of Justice, Washington, DC. http://www.ojp.usdoj.gov/bjs/pub/pdf/pjim06.pdf Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/pjim06.pdf
28. Salomon J.A., Weinstein M.C., Hammitt J.K., et al. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA 290 (2003) 228-237
29. Shojania K.G., Burton E.C., McDonald K.M., et al. Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. JAMA 289 (2003) 2849-2856
30. Solomon L., Flynn C., Muck K., and Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J. Urban. Health 81 (2004) 25-37
31. Spaulding A.C., Weinbaum C.M., Lau D.T., Sterling R., Seef L.B., Margolis H.S., et al. A framework for management of hepatitis C in prisons. Ann. Int. Med. 144 (2006) 762-769
32. StatsDirect Statistical Software, Version 2.7.2 (2008), StatsDirect Ltd, Cheshire, WA, UK
33. Tan J.A., Joseph T.A., and Saab S. Treating hepatitis C in the prison population is cost-saving. Hepatology 48 (2008) 1387-1395
34. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio. Am. J. Epidemiol. 131 (1990) 373-375
35. United States Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention (CDC), National Centers for Health Statistics (NCHS), Office of Analysis and Epidemiology (OAE). 2008. Compressed Mortality File (CMF) compiled from CMF 1968-1988, Series 20, No. 2A 2000, CMF 1989-1998, Series 20, No. 2E 2003 and CMF 1999-2003, Series 20, No. 2I 2006 on CDC WONDER On-line Database. Available at: http://wonder.cdc.gov/mortsql.html.
36. Weinbaum C., Lyerla R., and Margolis H.S. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm. Rep. 52 RR-1 (2003) 1-36